• 12 Apr 19

Executive interview - Selvita

Executive interview - Selvita

Ryvu Therapeutics SA | 0RKT | 0 90.0 0.9%

    • 173 views

 

Enjoying this article?

Get a £25 credit by sharing with your friends and colleagues via our Refer a Friend page. Each new subscriber gets a 10% discount and you get a free month off your bill every time.


Don't worry, if you're a Lite-Access/Free user we save all your credits for the day you decide to fully subscribe.


 

Allergy Therapeutics target $2B US allergy market - One2One Investor Forum

Companies: Allergy Therapeutics plc

Arecor CEO on Skye Bioscience partnership and the value of collaborations

Companies: Arecor Therapeutics PLC

Benchmark Holdings - Investor Presentation (Interim Results) - 12th June 2025

Companies: Benchmark Holdings Plc

Poolbeg Pharma, IXICO, ATOME, Caledonia Mining, Hercules - Small Cap Snapshot

Companies: Poolbeg Pharma PLC

Faron Pharmaceuticals presents promising data at ASCO 2025 conference patients

Companies: Faron Pharmaceuticals Oy

2025.04.22 Small Cap Snapshot_19.mp4

Companies: ImmuPharma plc

© Research Tree 2025

  • Apple Store
  • Play Store

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top